Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, will hold its Annual General Meeting (‘AGM’) today at 11am at Omega
Omega Diagnostics Gp (ODX.L) VISITECT ® COVID-19 antigen test self-test submission update
All supporting data and documentation now submitted to Omega’s European Notified Body
Omega Diagnostics Gp (ODX.L) Posting of Annual Report & Accounts & Notice of AGM
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that the Notice of Annual General Meeting (‘AGM’).
Omega Diagnostics Gp (ODX.L) AbC-19 monitors vaccine response to variants
AbC-19TM test to monitor vaccine responses to variants of concern AbC-19TM able to detect antibody response to different vaccines as well as natural infection
Omega Diagnostics Gp (ODX.L) Final Results
FOR THE YEAR ENDED 31 MARCH 2021
Omega Diagnostics Gp (ODX.L) AbC-19 rapid antibody test performance evaluation
Peer-reviewed performance evaluation and self-test user experience of AbC 19TM
Omega Diagnostics Gp (ODX.L) FDA submission for Emergency Use Authorization
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that following completion of the of US performance studies.
Omega Diagnostics Gp (ODX.L) Statement re. Media Comment
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the recent media comment that Mologic Ltd have requested for Porton Down to evaluate
Omega Diagnostics Gp (ODX.L) Regulatory progress for VISITECT® COVID-19 test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, provides the following update on VISITECT® COVID-19 Antigen test regulatory approvals.
Avacta Group PLC (AVCT.L) Distribution Agreement for COVID-19 Antigen Test
Global, exclusive, direct-to-consumer sales and marketing agreement for COVID-19 self-testing